[go: up one dir, main page]

WO2001094537A3 - Nouveau polypeptide, nadh-ubiquinone oxydoreductase humaine 21.89, et polynucleotide codant ce polypeptide - Google Patents

Nouveau polypeptide, nadh-ubiquinone oxydoreductase humaine 21.89, et polynucleotide codant ce polypeptide Download PDF

Info

Publication number
WO2001094537A3
WO2001094537A3 PCT/CN2001/000854 CN0100854W WO0194537A3 WO 2001094537 A3 WO2001094537 A3 WO 2001094537A3 CN 0100854 W CN0100854 W CN 0100854W WO 0194537 A3 WO0194537 A3 WO 0194537A3
Authority
WO
WIPO (PCT)
Prior art keywords
ubiquinone oxidoreductase
polynucleotide encoding
human nadh
nadh ubiquinone
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2001/000854
Other languages
English (en)
Chinese (zh)
Other versions
WO2001094537A2 (fr
Inventor
Yumin Mao
Yi Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Biowindow Gene Development Inc
Original Assignee
Shanghai Biowindow Gene Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Development Inc filed Critical Shanghai Biowindow Gene Development Inc
Priority to AU89496/01A priority Critical patent/AU8949601A/en
Publication of WO2001094537A2 publication Critical patent/WO2001094537A2/fr
Anticipated expiration legal-status Critical
Publication of WO2001094537A3 publication Critical patent/WO2001094537A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne un nouveau polypeptide, une NADH-ubiquinone oxydoréductase humaine 21.89, et un polynucléotide codant ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment du syndrome de Down, de démence, de tumeurs, des troubles du développement, d'inflammations et de maladies immunitaires etc. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant la NADH-ubiquinone oxydoréductase humaine 21.89.
PCT/CN2001/000854 2000-05-24 2001-05-21 Nouveau polypeptide, nadh-ubiquinone oxydoreductase humaine 21.89, et polynucleotide codant ce polypeptide Ceased WO2001094537A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU89496/01A AU8949601A (en) 2000-05-24 2001-05-21 A novel polypeptide, a human nadh-ubiquinone oxidoreductase 21.89 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN00115843.0 2000-05-24
CN 00115843 CN1324938A (zh) 2000-05-24 2000-05-24 一种新的多肽——人nadh泛醌氧化还原酶21.89和编码这种多肽的多核苷酸

Publications (2)

Publication Number Publication Date
WO2001094537A2 WO2001094537A2 (fr) 2001-12-13
WO2001094537A3 true WO2001094537A3 (fr) 2004-04-08

Family

ID=4585285

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000854 Ceased WO2001094537A2 (fr) 2000-05-24 2001-05-21 Nouveau polypeptide, nadh-ubiquinone oxydoreductase humaine 21.89, et polynucleotide codant ce polypeptide

Country Status (3)

Country Link
CN (1) CN1324938A (fr)
AU (1) AU8949601A (fr)
WO (1) WO2001094537A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114591926B (zh) * 2022-04-02 2024-02-13 南开大学 一种人源呼吸链复合物i的纯化方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047666A1 (fr) * 1998-03-18 1999-09-23 Shanghai Second Medical University Gene humain homologue de ci-mnll: cbdfmd04
CN1261104A (zh) * 1999-01-20 2000-07-26 复旦大学 一种人氧化还原酶亚基及其编码序列,以及制法和用途

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047666A1 (fr) * 1998-03-18 1999-09-23 Shanghai Second Medical University Gene humain homologue de ci-mnll: cbdfmd04
CN1261104A (zh) * 1999-01-20 2000-07-26 复旦大学 一种人氧化还原酶亚基及其编码序列,以及制法和用途

Also Published As

Publication number Publication date
CN1324938A (zh) 2001-12-05
AU8949601A (en) 2001-12-17
WO2001094537A2 (fr) 2001-12-13

Similar Documents

Publication Publication Date Title
WO2001092523A3 (fr) Nouveaux polynucleotides humains et polypeptides codes par ceux-ci
WO2005047322A3 (fr) Procedes et compositions du facteur viii
WO2001036645A3 (fr) Nouveaux polypeptides et acides nucleiques codant les memes
WO2001090366A3 (fr) Nouveaux polynucleotides humains et polypeptides codes par celui-ci
WO2002097097A3 (fr) Compositions et procedes d'augmentation de la resistance au stress des plantes
WO2001094537A3 (fr) Nouveau polypeptide, nadh-ubiquinone oxydoreductase humaine 21.89, et polynucleotide codant ce polypeptide
WO2001062928A3 (fr) Polypeptides et acides nucleiques codant pour
WO2001070978A3 (fr) Nouveaux polypeptides et acides nucleiques codant ces polypeptides
WO2002060382A3 (fr) Composes et utilisations
WO2001036638A8 (fr) Nouveaux polypeptides et acides nucleiques codant pour ces polypeptides
WO2001083686A3 (fr) Nouveau polypeptide, proteine humaine 9 semblable a l'inclusine, et polynucleotide codant pour ce polypeptide
WO2001068851A3 (fr) Nouveaux polypeptides et acides nucleiques les codant
WO2001094539A3 (fr) Nouveau polypeptide, facteur humain d'inhibition 11 de type kazal, et polynucleotide codant ce polypeptide
WO2001074997A3 (fr) Nouveau polypeptide, proteine humaine de reception cannabinoide 11, et polynucleotide codant pour ce polypeptide
WO2001075017A3 (fr) Nouveau polypeptide, dihydroorotase humaine 17, et polynucleotide codant pour ce polypeptide
WO2001079437A3 (fr) Nouveau polypeptide, facteur humain de transcription de la differentiation cellulaire 14, et polynucleotide codant pour ce polypeptide
WO2001075013A3 (fr) Nouveau polypeptide, kinase humaine cycline-dependante 14, et polynucleotide codant pour ce polypeptide
WO2001075047A3 (fr) Nouveau polypeptide, sous-unite humaine 10 de flavoproteine, et polynucleotide codant pour ce polypeptide
WO2001023572A3 (fr) Nouveaux polynucleotides et polypeptides codes par ces derniers
WO2001075031A3 (fr) Nouveau polypeptide, thyrotropine humaine 12, et polynucleotide codant pour ce polypeptide
WO2002010400A1 (fr) Nouveau polypeptide, arnt-guanine transglycosylase 17.82, et polynucleotide codant ce polypeptide
WO2001074998A3 (fr) Nouveau polypeptide, proteine humaine de regulation 10 de la serine proteinase, et polynucleotide codant pour ce polypeptide
WO2002000826A3 (fr) Nouveau polypeptide, proteine humaine de methylation d'adn, et polynucleotide codant ce polypeptide
GB0025170D0 (en) Novel compounds
WO2002002601A3 (fr) Polypeptides mutants de préséniline 1 et de préséniline 2

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP